Nanosilicon spray is a novel alternative treatment for mild plaque psoriasis

Catia de Felipe, Sergio Chimenti

Research output: Contribution to journalArticle

Abstract

Background: Psoriasis is a common chronic cell-mediated inflammatory skin disease with a strong impact on patient's quality of life, attitude, daily physical and social activities. Nanosilicon, the smallest form of silicon, showed good results in the treatment of irritated skin with an anti-inflammatory and antioxidant effect. Objectives: To assess the efficacy, tolerability and safety of nanosilicon spray in mild plaque psoriasis involving sensitive areas. Methods: Fifty patients with a body surface area <35% were enrolled into a prospective open label clinical study. Patients were treated for 12 weeks with a 3-4 times a day nanosilicon topical spray application. Efficacy and safety were assessed during the therapy and during a 3-month follow up period. Results: The study demonstrated a high clinical remission rate which progressively increased throughout therapy (8% at week 2, 34.1% at week 6 and 56.8% at week 12). No serious adverse events were reported. Conclusions: The study suggests that nanosilicon spray, applied three to four times a day, is an effective topical treatment for mild plaque psoriasia involving less than 35% of the body surface and sensitive areas.

Original languageEnglish
Pages (from-to)283-285
Number of pages3
JournalJournal of Plastic Dermatology
Volume4
Issue number3
Publication statusPublished - Sep 2008

Fingerprint

Psoriasis
Body Surface Area
Safety
Silicon
Therapeutics
Skin Diseases
Anti-Inflammatory Agents
Antioxidants
Quality of Life
Exercise
Skin

Keywords

  • Nanosilicon
  • Plaque psoriasis
  • Sensitive areas

ASJC Scopus subject areas

  • Dermatology

Cite this

Nanosilicon spray is a novel alternative treatment for mild plaque psoriasis. / de Felipe, Catia; Chimenti, Sergio.

In: Journal of Plastic Dermatology, Vol. 4, No. 3, 09.2008, p. 283-285.

Research output: Contribution to journalArticle

@article{e5b9b52ed1614f55a46e07e7eb2bde68,
title = "Nanosilicon spray is a novel alternative treatment for mild plaque psoriasis",
abstract = "Background: Psoriasis is a common chronic cell-mediated inflammatory skin disease with a strong impact on patient's quality of life, attitude, daily physical and social activities. Nanosilicon, the smallest form of silicon, showed good results in the treatment of irritated skin with an anti-inflammatory and antioxidant effect. Objectives: To assess the efficacy, tolerability and safety of nanosilicon spray in mild plaque psoriasis involving sensitive areas. Methods: Fifty patients with a body surface area <35{\%} were enrolled into a prospective open label clinical study. Patients were treated for 12 weeks with a 3-4 times a day nanosilicon topical spray application. Efficacy and safety were assessed during the therapy and during a 3-month follow up period. Results: The study demonstrated a high clinical remission rate which progressively increased throughout therapy (8{\%} at week 2, 34.1{\%} at week 6 and 56.8{\%} at week 12). No serious adverse events were reported. Conclusions: The study suggests that nanosilicon spray, applied three to four times a day, is an effective topical treatment for mild plaque psoriasia involving less than 35{\%} of the body surface and sensitive areas.",
keywords = "Nanosilicon, Plaque psoriasis, Sensitive areas",
author = "{de Felipe}, Catia and Sergio Chimenti",
year = "2008",
month = "9",
language = "English",
volume = "4",
pages = "283--285",
journal = "Journal of Plastic Dermatology",
issn = "2035-0686",
publisher = "International-Italian Society of Plastic and Oncologic Dermatology",
number = "3",

}

TY - JOUR

T1 - Nanosilicon spray is a novel alternative treatment for mild plaque psoriasis

AU - de Felipe, Catia

AU - Chimenti, Sergio

PY - 2008/9

Y1 - 2008/9

N2 - Background: Psoriasis is a common chronic cell-mediated inflammatory skin disease with a strong impact on patient's quality of life, attitude, daily physical and social activities. Nanosilicon, the smallest form of silicon, showed good results in the treatment of irritated skin with an anti-inflammatory and antioxidant effect. Objectives: To assess the efficacy, tolerability and safety of nanosilicon spray in mild plaque psoriasis involving sensitive areas. Methods: Fifty patients with a body surface area <35% were enrolled into a prospective open label clinical study. Patients were treated for 12 weeks with a 3-4 times a day nanosilicon topical spray application. Efficacy and safety were assessed during the therapy and during a 3-month follow up period. Results: The study demonstrated a high clinical remission rate which progressively increased throughout therapy (8% at week 2, 34.1% at week 6 and 56.8% at week 12). No serious adverse events were reported. Conclusions: The study suggests that nanosilicon spray, applied three to four times a day, is an effective topical treatment for mild plaque psoriasia involving less than 35% of the body surface and sensitive areas.

AB - Background: Psoriasis is a common chronic cell-mediated inflammatory skin disease with a strong impact on patient's quality of life, attitude, daily physical and social activities. Nanosilicon, the smallest form of silicon, showed good results in the treatment of irritated skin with an anti-inflammatory and antioxidant effect. Objectives: To assess the efficacy, tolerability and safety of nanosilicon spray in mild plaque psoriasis involving sensitive areas. Methods: Fifty patients with a body surface area <35% were enrolled into a prospective open label clinical study. Patients were treated for 12 weeks with a 3-4 times a day nanosilicon topical spray application. Efficacy and safety were assessed during the therapy and during a 3-month follow up period. Results: The study demonstrated a high clinical remission rate which progressively increased throughout therapy (8% at week 2, 34.1% at week 6 and 56.8% at week 12). No serious adverse events were reported. Conclusions: The study suggests that nanosilicon spray, applied three to four times a day, is an effective topical treatment for mild plaque psoriasia involving less than 35% of the body surface and sensitive areas.

KW - Nanosilicon

KW - Plaque psoriasis

KW - Sensitive areas

UR - http://www.scopus.com/inward/record.url?scp=58649104466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58649104466&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 283

EP - 285

JO - Journal of Plastic Dermatology

JF - Journal of Plastic Dermatology

SN - 2035-0686

IS - 3

ER -